HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

3-D Pharmaceuticals licenses GW 395058 from GSK

Executive Summary

3-Dimensional Pharmaceuticals (drug discovery tools) has licensed exclusive worldwide rights to develop, market, and distribute GlaxoSmithKline's pre-IND GW 395058. The compound is in development as a therapeutic for thrombocytopenia, or low blood platelet count.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Reverse Licensing
    • Includes Contract
    • Includes Equity

Related Companies